Felix Rosenow

 

 

Last Name

Rosenow

First Name

Felix

Institution

Goethe University Frankfurt, Germany

Short CV

Professional and University Career

Director, Epilepsy Center Frankfurt Rhine-Main and Associate Professor, Goethe-University Frankfurt, Faculty of Medicine, since 2015

Member of several International research Consortia: EpiK4, EPI25, EuroEpinomics, ILAE Consortium on complex epilepsies, SENSE-Consortium, ILAE comission on evidence based epilepsy surgery

Master of Health Business Administration University Erlangen-Nürnberg 2012

Associate Professor, Philipps-University Marburg, Faculty of Medicine, since 2015

Habilitation in Neurology, Philipps University Marburg, Germany, 1998

Head, Epilepsy Center Hessen-Marburg 1997-2015

Clincal Fellowship, Section of Epilepsy and Sleep, Department of Neurology, The Cleveland Clinic Foundation, Cleveland, USA, 1995-1997

Chamber-certification in Neurology, 1994

Clinical training in Neurology and Psychiatry (1 year), University of Cologne, Germany, 1988-89 and 1990-1994

MD (Dr. med.), University of Cologne, Germany, 1992

MD-theses research stipend of the Max-Planck-Institute for Neurological Research, Cologne, Germany 1989

Medical School: Free University of Berlin, Germany, 1982-1988

Grants

ERAPerMed Raise-Genic , 1Mio€ (300.000 for GU from EU/BMBF) 2019-22

Coordinator, EpilepsieNetz Hessen (Telemedine network project), Funded through the Hessian Ministries of Social Affairs and Integration and of  Research and Art's LOEWE initiative. Total funding 1.3Mio €, 2018 – 2021

Coordinator,  Center for Personalized Translational Epilepsy Research (CePTER) Funded through the Hessian Ministry of Research and Art's LOEWE initiative. Total funding 4.7 Mio €, 2018 – 2021

Co-Coordinator, EpimiRNA consortium (www.epimirna.eu): Funded through the European Union’s Seventh Framework Programme (FP7), Grant Agreement no. 602130. Total funding: 11.5 Mio €, Philipps-University Marburg 3 Mio €, 2013 – 18

List of

ten relevant publications

535 Publications, 10497 citations, H-index 49 (Google Scholar, February 2018)

Full list: https://www.ncbi.nlm.nih.gov/pubmed/?term=Rosenow+F

Kellinghaus C, …Rosenow F. Factors predicting cessation of status epilepticus in clinical practice - data from a prospective observational registry (SENSE). Ann Neurol. 2019 Jan 20. doi: 10.1002/ana.25416. [Epub ahead of print]

International League Against Epilepsy Consortium on Complex Epilepsies. Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nat Commun. 2018 Dec 10;9(1):5269.

Blumcke I,….Rosenow F,  et al.  Histopathological Findings in Brain Tissue Obtained from Epilepsy Surgery. New Engl J Med, 2017 377(17):1648-1656.

Baulac M, Rosenow F, et al . Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly-diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol, 2017;16(1):43-54

Reschke CR, …Rosenow F, Henshall DC. Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy. Mol Ther Nucleic Acids 2017;6:45-56

Rajman M, …Rosenow F et al. A microRNA-129-5p/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses. The EMBO Journal, 2017 DOI 10.15252/embj.201695748

Raoof R, … Rosenow F, et al. Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Scientific Reports 2017 12;7(1):3328.

Pérez-Palma E, …Rosenow F et al. Heterogeneous contribution of microdeletions in the development of common generalised and focal epilepsies. J Med Genet. 2017 Sep;54(9):598-606.

Henshall DC,…. Rosenow F. MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol, 2016;15(13):1368-76

Helbig I, … Rosenow F, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nature Genetics, 2009;41:160-2

Rosenow F, Lüders H. Presurgical evaluation of epilepsy. Brain, 2001;124: 1683-1700

Copyright © key4events - All rights reserved